Home » Market News » DirectorsTalk Highlights » The truth about CBD: the hemp wellness market is worth £300 million
Sativa Group

The truth about CBD: the hemp wellness market is worth £300 million

It’s a sunny afternoon in Somerset, and I’m standing in a two-acre field of cannabis. The plants don’t smell particularly potent; they’re gangly creatures that look like a cross between a nettle and a fern. They look innocuous, but I had to secure a pass to come here, ­accompanied by Dr Nick Horniman, one of the UK’s leading experts on medicinal cannabis, and George Thomas, managing director of George Botanicals, a CBD products manufacturer that is part of the ­Sativa Group. 

The plot has been approved by the Home Office for research purposes, and propagated with a low-THC strain of cannabis. THC (tetrahydrocannabinol) is the mind-altering and illegal substance found in the cannabis plant, but nobody at Sativa Group is interested in that particular compound; they’re interested in CBD, or cannabidiol, one of the legal, non-psychoactive chemicals also found in the hemp plant.  

Sativa Group PLC (NEX:SATI) is a seed to consumer medicinal cannabis and cannabidiol (CBD) wellness business, focused on the smart-sourcing of the raw material, advanced extraction, manufacture, testing, distribution, and research & development of medicinal cannabis and CBD products.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.